InjectionMRP Under Process
Official PMBI MRP is being updated for catalog code 2805.
Locate Jan Aushadhi KendraClinical Overview
Methylcobalamin Injection (500mcg/ml, 1500mcg/ml) is a parenteral coenzyme form of vitamin B12 on the WHO Model List framework. Bypasses intestinal intrinsic factor absorption barriers to replenish intracellular cobalamin pools, promoting neuronal myelin sheath synthesis, axonal regeneration, and methionine synthase remethylation of homocysteine. Indicated for severe peripheral neuropathy, diabetic neuropathy, megaloblastic anemia, subacute combined degeneration of the spinal cord, and pernicious anemia.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Administer by intramuscular (IM) or slow intravenous (IV) injection: 500 mcg to 1500 mcg three times weekly or daily as directed by physician. Protect solution from light.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Extremely safe. Common: Injection site pain, headache, transient diarrhea. Rare: Hypokalemia during initial treatment of severe megaloblastic anemia (rapid erythrocyte production consumes potassium).
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Monitor serum potassium during initial therapy of severe megaloblastic anemia. Protect ampoules from direct light.
Medical Disclaimer: Statutory Nutritional & Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice or clinical dietetic guidance. Dietary supplements, micronutrients, parenteral electrolytes, and specialized clinical nutrition should be used under the supervision of a registered medical practitioner or clinical nutritionist.
Vitamin B-Complex Tablets (B1, B2, B3, B5, B6, B12)
Thiamine Hydrochloride Tablets (100mg) is an oral Vitamin B1 preparation on the WHO Model List of Essential Medicines for prevention and treatment of thiamine deficiency, dry and wet beriberi, and nutritional support in chronic alcoholism.
Vitamin B-Complex Syrup
Thiamine Hydrochloride Tablets (100mg) is an oral Vitamin B1 preparation on the WHO Model List of Essential Medicines for prevention and treatment of thiamine deficiency, dry and wet beriberi, and nutritional support in chronic alcoholism.
Methylcobalamin 1500mcg, L- Carnitine L- Tartrate 500mg and Folic Acid 1.5mg Tablets
Methylcobalamin / Mecobalamin Tablets (500mcg, 1500mcg) and Orally Disintegrating Strips (1500mcg; alone or with Alpha Lipoic Acid, Benfotiamine, Folic Acid, Pyridoxine) is an active neurotropic coenzyme form of vitamin B12 on the WHO Model List framework. It functions as a methyl donor in homocysteine-to-methionine conversion, essential for phosphatidylcholine and myelin sheath synthesis, nucleic acid synthesis, and nerve regeneration. Indicated for diabetic peripheral neuropathy, alcoholic neuropathy, megaloblastic anemia, drug-induced neuropathy (isoniazid, metformin), and sciatica.
Folic Acid 15mg, Cyanocobalamin 500mcg & Nicotinamide 200mg Injection (10ml)
Folic Acid (5mg, 15mg) and L-Methylfolate Calcium (1mg, 2.8mg, 7.5mg Tablets) is an essential water-soluble B-vitamin and active tetrahydrofolate derivative on the WHO Model List of Essential Medicines. L-Methylfolate is the active methylated metabolite (5-MTHF) that crosses the blood-brain barrier directly without requiring enzymatic reduction by methylenetetrahydrofolate reductase (MTHFR). Transports one-carbon units for purine and thymidylate synthesis, essential for DNA replication, cell division, and homocysteine remethylation. Indicated for prevention of neural tube defects (spina bifida, anencephaly) in pregnancy, treatment of folate deficiency megaloblastic anemia, hyperhomocysteinemia, and adjunctive therapy in depression.